MM-359 Real-World Treatment Characteristics and Clinical Outcomes in Medicare Beneficiaries With Newly Diagnosed Multiple Myeloma (NDMM) Treated With Bortezomib in Combination With Lenalidomide and Dexamethasone (VRd)

Joshua Richter, Dominick Latremouille-Viau, Eleanor Saunders, Peggy L. Lin, Christina Tekle

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'MM-359 Real-World Treatment Characteristics and Clinical Outcomes in Medicare Beneficiaries With Newly Diagnosed Multiple Myeloma (NDMM) Treated With Bortezomib in Combination With Lenalidomide and Dexamethasone (VRd)'. Together they form a unique fingerprint.

Medicine & Life Sciences